Flaxseed Cardiometabolic Wellness Meta-Analysis Evidence Table

Structured evidence table for Flaxseed Cardiometabolic Wellness Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Flaxseed Cardiometabolic Wellness Meta-AnalysisWomen’s risk of CVD increases postmenopausally via a multitude of complex physiological factors, including distinct patterns of sex hormone changes and increase in weight, blood pressure, and lipids ().3Rahman Tabassum (2026)Cardiovascular disease risk reduction interventions for Indigenous women: an umbrella review
Flaxseed Cardiometabolic Wellness Meta-AnalysisThere is consistent evidence that CVD in women remains ‘understudied, under-recognized, underdiagnosed, and undertreated’ ().3Rahman Tabassum (2026)Cardiovascular disease risk reduction interventions for Indigenous women: an umbrella review
Flaxseed Cardiometabolic Wellness Meta-AnalysisThere is also persistent disparity in reduction in CVD-related mortality in women between high-income versus low- and middle-income countries, and inequities remain in CVD assessment and evidence-based management, particularly among younger women (,).3Rahman Tabassum (2026)Cardiovascular disease risk reduction interventions for Indigenous women: an umbrella review
Flaxseed Cardiometabolic Wellness Meta-AnalysisBritish Heart Foundation 2024 World Health Organisation 2024 The Lancet 2023 Thomas and Braus 1998 Maas and Appelman 2010 et al El Khoudary.3Rahman Tabassum (2026)Cardiovascular disease risk reduction interventions for Indigenous women: an umbrella review
Flaxseed Cardiometabolic Wellness Meta-AnalysisUnhealthy aging is a growing global concern, characterized by the accelerated decline in physiological and metabolic functions, leading to increased susceptibility to age-related diseases.3Kunutsor Setor K. (2025)Dietary flaxseed: Cardiometabolic benefits and its role in promoting healthy aging
Flaxseed Cardiometabolic Wellness Meta-AnalysisAmong these are cardiometabolic diseases, including hypertension, metabolic syndrome (MetS), metabolic dysfunction-associated steatotic liver disease (MASLD), type 2 diabetes (T2D), chronic kidney disease (CKD), and cardiovascular diseases (CVDs), which collectively represent a significant public health burden.3Kunutsor Setor K. (2025)Dietary flaxseed: Cardiometabolic benefits and its role in promoting healthy aging
Flaxseed Cardiometabolic Wellness Meta-AnalysisThis condition, characterized by fat accumulation in the liver independent of alcohol consumption, often coexists with obesity, MetS, and T2D, significantly increasing the risk of liver cirrhosis and CVD [].3Kunutsor Setor K. (2025)Dietary flaxseed: Cardiometabolic benefits and its role in promoting healthy aging
topicFlaxseed Cardiometabolic Wellness Meta-Analysis
claimWomen’s risk of CVD increases postmenopausally via a multitude of complex physiological factors, including distinct patterns of sex hormone changes and increase in weight, blood pressure, and lipids ().
evidence level3
citationRahman Tabassum (2026)
sourceCardiovascular disease risk reduction interventions for Indigenous women: an umbrella review
topicFlaxseed Cardiometabolic Wellness Meta-Analysis
claimThere is consistent evidence that CVD in women remains ‘understudied, under-recognized, underdiagnosed, and undertreated’ ().
evidence level3
citationRahman Tabassum (2026)
sourceCardiovascular disease risk reduction interventions for Indigenous women: an umbrella review
topicFlaxseed Cardiometabolic Wellness Meta-Analysis
claimThere is also persistent disparity in reduction in CVD-related mortality in women between high-income versus low- and middle-income countries, and inequities remain in CVD assessment and evidence-based management, particularly among younger women (,).
evidence level3
citationRahman Tabassum (2026)
sourceCardiovascular disease risk reduction interventions for Indigenous women: an umbrella review
topicFlaxseed Cardiometabolic Wellness Meta-Analysis
claimBritish Heart Foundation 2024 World Health Organisation 2024 The Lancet 2023 Thomas and Braus 1998 Maas and Appelman 2010 et al El Khoudary.
evidence level3
citationRahman Tabassum (2026)
sourceCardiovascular disease risk reduction interventions for Indigenous women: an umbrella review
topicFlaxseed Cardiometabolic Wellness Meta-Analysis
claimUnhealthy aging is a growing global concern, characterized by the accelerated decline in physiological and metabolic functions, leading to increased susceptibility to age-related diseases.
evidence level3
citationKunutsor Setor K. (2025)
sourceDietary flaxseed: Cardiometabolic benefits and its role in promoting healthy aging
topicFlaxseed Cardiometabolic Wellness Meta-Analysis
claimAmong these are cardiometabolic diseases, including hypertension, metabolic syndrome (MetS), metabolic dysfunction-associated steatotic liver disease (MASLD), type 2 diabetes (T2D), chronic kidney disease (CKD), and cardiovascular diseases (CVDs), which collectively represent a significant public health burden.
evidence level3
citationKunutsor Setor K. (2025)
sourceDietary flaxseed: Cardiometabolic benefits and its role in promoting healthy aging
topicFlaxseed Cardiometabolic Wellness Meta-Analysis
claimThis condition, characterized by fat accumulation in the liver independent of alcohol consumption, often coexists with obesity, MetS, and T2D, significantly increasing the risk of liver cirrhosis and CVD [].
evidence level3
citationKunutsor Setor K. (2025)
sourceDietary flaxseed: Cardiometabolic benefits and its role in promoting healthy aging

Source documents

  1. Cardiovascular disease risk reduction interventions for Indigenous women: an umbrella review
  2. Dietary flaxseed: Cardiometabolic benefits and its role in promoting healthy aging